# Medical Research and Surveillance Services

Canonical: https://abierto.us/opportunities/ht942525r0004

- Solicitation number: HT942525R0004
- Notice type: Solicitation
- Status: Awarded to Supa71 Company Limited
- Department: Department of Defense
- Agency: Defense Health Agency (Dha)
- Contracting office: Army Med Res Acq Activity (HT9425)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product or service code: AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Place of performance: Laos, THA
- First posted: October 7, 2024
- Last posted: October 24, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/331f386ec02742cc9e413535f4691591/view

## Description

The purpose of this requirement is to provide non-personal service(s) services and expertise to conduct medical research and surveillance for AFRIMS’ projects within the country of Laos.

This support shall include field advertisement, the site rental space for subject enrollment, subject compensation, sample collection, sample processing, point-of-care, and preliminary lab testing, moderate to complex lab testing, pathogen identification, sample storage, and transporting of the samples to AFRIMS or another lab to conduct more advanced laboratory testing.

Surveillance and research shall be on malaria prevalence and antimalarial drug resistance, bacteria with antimicrobial resistance, sexually transmitted pathogens, respiratory viral pathogens, bacterial pathogens, agents of parasitic disease and other emerging infections found in the LPAF ranks and in the Laos citizens.

Products that may be evaluated in clinical trials include anti-malarial drugs and/or vaccines, anti-viral drugs, anti-microbial drugs, other potential candidates with activity against infectious disease agents as well as diagnostic tests. The contractor shall provide office space, utilities, as well as security per local regulations. Please see solicitation for additional information. The purpose of Amendment 0001 is to answer questions from potential offerors. There are no other changes.

## Award on USAspending

- Recipient: Supa71 Company Limited (UEI MWSLNC43D1C8)
- Contract: HT942525P0035, purchase order
- Obligated: $111,467.89
- Competition: Full and Open Competition, 3 offers received
- Link: solicitation number HT942525R0004 equals the FPDS solicitation identifier; same awarding office HT9425 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_HT942525P0035_9700_-NONE-_-NONE-/


## Publications

- October 7, 2024: Solicitation, due November 7, 2024 at 1:00 PM EST. Notice 5c8272bdfda141c3bfac0a32d19c34f0. https://sam.gov/workspace/contract/opp/5c8272bdfda141c3bfac0a32d19c34f0/view
- October 24, 2024: Solicitation, due November 7, 2024 at 1:00 PM EST. Notice 331f386ec02742cc9e413535f4691591. https://sam.gov/workspace/contract/opp/331f386ec02742cc9e413535f4691591/view

## Points of contact

- John Fitzsimmons, john.l.fitzsimmons8.civ@health.mil
- Jennifer Jackson, jennifer.c.jackson18.civ@health.mil

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/ht942525r0004.